Adenovirus E1A fragments for use in anti-cancer therapies

Aug. 28, 2012

Adenovirus E1A fragments for use in anti-cancer therapies

Technology description

Category:

Therapeutic

Summary:

Up-regulation of the HER2/neu proto-oncogene occurs in several types of human cancer, including breast, ovary and prostate. HER2 up-regulation in breast cancer is predictive of aggressive disease with a poor prognosis. In addition, several studies have shown that elevated HER2 levels decrease the susceptibility of cancer cells to chemotherapy drugs. Further, treatment with siRNAs that inhibit HER2 translation was found to promote growth arrest and apoptosis of breast cancer cell lines.

This invention relates to cancer therapies utilizing a fragment of adenovirus E1A that represses oncogenic genes, such as HER2/neu.

由于技术保密工作限制，技术信息无法完全展现，请通过邮箱或短信联系我们，获取更多技术资料。